Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Arena Pharmaceutical (ARNA +1.4%) trades in the green today after earlier disclosing the price...

  • Monday, February 25, 2:45 PM ET
    Arena Pharmaceutical (ARNA +1.4%) trades in the green today after earlier disclosing the price for a 60-day supply of Belviq 10-mg tablets at $199.50. This compares with Vivus' (VVUS +1%) Qsymia, which retails for $160 per month at a medium dose and $220 per month for the higher dose. Analysts note the success of Belviq will largely depend on lower co-payments and broader insurance coverage, which could come in the next two years.
Track new comments on this story

This news story has 5 comments:

  •  
    March 4th.......

    The first day of sales........
    25 Feb, 03:01 PM Reply Like
  •  
    Gooooooooooooooo ARNA !!!!!!!!!!!!!!!!!!!!
    25 Feb, 03:10 PM Reply Like
  •  
    Just for clarification, if you read the 8-k, $199.50 is the price that Esai will pay to Arena. Esai will then re-sell it to the pharmacy who will in turn resell it to the patient.
    25 Feb, 05:14 PM Reply Like
  •  
    Seeking Alfalfa missed again here. Esai isn't paying $199.50 to ARNA .They will reimburse them 31% of $199.50 for each sale and keep the rest themselves.
    26 Feb, 01:29 AM Reply Like
  •  
    @gazoo99....March 4th ? How do you know ?
    26 Feb, 07:03 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »